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Abstract 
Purpose: To investigate the protective effect of Millettia pulchra Kurz var. Laxior (Dunn) Z. Wei 
(Yulangsan) leaf (YLSL) on chemically-induced liver injury in mice.  
Methods: Models of carbon tetrachloride (CCl4) and D-galactosamine (D-GalN)-induced liver injury in 
Kunming mice were prepared by intraperitoneal injection. Sixty mice were randomly divided into normal 
saline (NS) group, liver-injury group, low-, medium- and high-dose YLSL groups (7.5, 15 and 30 g/kg 
dose, respectively), and biphenyldicarboxylate (BPDC) group, with 10 animals per group. Indices for 
liver, spleen and thymus were assessed. Serum aspartate transaminase (AST) and alanine 
aminotransferase (ALT) activities, levels of malondialdehyde (MDA) in liver tissues and reduced 
glutathione (GSH) as well as activities of superoxide dismutase (SOD) and glutathione peroxidase 
(GSH-Px) in liver tissue were assayed. Liver tissue damage was assessed histologically. 
Results: YLSL could significantly decrease the elevation of AST or ALT in liver injuries induced by CCl4 
or D-GalN in mice, which showed a dose-effect relationship obviously. The high dose YLSL significantly 
decreased thymus weight relative to CCl4 and D-GalN (CCL4 CCL4+YLSL: 4.4213 ± 1.0544 vs 3.7120 ± 
0.8534; D-GalN vs YLSL + D-GalN: 3.7272 ± 1.1655 vs 1.9548 ± 1.2996, p < 0.01). However, SOD 
activity was significantly increased (p < 0.01, p < 0.05). In treatment groups exposed to CCl4, GSH-Px 
activity was significantly increased (p < 0.01) and GSH levels decreased (middle dose group and 
positive control group). In treatment groups with D-GalN, GSH content was significantly increased (p < 
0.01 or p < 0.05), while GSH-Px activity decreased (p <0.01). 
Conclusion: YLSL has protective effect against chemically-induced liver injury in mice. The mechanism 
may be related to attenuation of free radical-induced lipid peroxidation. 
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Millettia pulchra Kurz var. Laxior(Dunn)Z. Wei 
also known as Yulangsan (YLS) or  
Longyanshen, is used as an analgesic, anti-
inflammatory, sedative memory-enhancing, 
immunity-boosting and anti-stress agent. The 
roots of YLS contain flavonoids [2], saponins [3] 
and polysaccharides [4]. Studies have shown 
that the aqueous extract of YLS roots has 
hypotensive, free radical-scavenging, myocardial 
ischemia and reperfusion injury-reducing 
properties [5]. It also has anti-dementia and anti-
inflammatory [6], as well as hepatoprotective 
effects [7,8]. Studies have so far concentrated 
mostly on Yulangsan roots, to the exclusion of 
the leaves. 
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In the present study, the hepatoprotective effects 
of alcohol extract of Yulangsan leaves against 
chemical-induced liver injury were investigated in 
SPF Kunming mice through a combination of 






SPF Kunming mice (half male and half female, 
weighing 20 ± 2 g) were provided by the Guangxi 
Medical University Experimental Animal Center 
(Shuangyong Road No. 22, Nanning City, 
Guangxi Province, China). Experimental animal 
production and occupation licenses were SCXKG 
Gui 2009-0002, and SYXKG Gui 2009-0004, 
respectively. This research was approved by the 
Animal Ethical Committee of Guangxi Medical 
University Experimental Animal Center according 
to "Principles of Laboratory Animal Care" (NIH 
publication no. 85-23, revised 1985) [7]. 
 
Materials and reagents  
 
The plant was collected from Xinxu in the suburb 
of Lingshan Guangxi Province in 2014, and was 
identified as Millettia pulchra Kurz var. Laxior 
(Dunn) Z.Wei (Yulangsan) leaf by Professor 
Maoxiang Nai (Guangxi institute of Chinese 
Medicine & Pharmaceutical Science, Nanning). A 
voucher specimen (no. YLS 201406-03) was 
kept at the herbarium 0f Experimental Center Of 
The School Of Pharmacy, Guangxi Medical 
University. Yulangsan leaf (YLSL) alcohol extract 
was prepared by a method utilizing 70 % 
methanol for extraction for 2 h at reflux; analytical 
grade carbon tetrachloride (CCl4) was purchased 
from Chengdu Kelong Chemical Reagent Factory 
(Sichuan, China). D-GalN was provided by MP 
Biomedicals LLC (Shanghai, China). Bifendate 
dropping pills were purchased form Guangzhou 
Xingqun Pharmaceutical Co., Ltd (Guangdong 
Province, China); sodium chloride injection were 
purchased from Guizhou Tiandi Pharmaceutical 
Co., Ltd. (Guangdong Province,China), while 
Coomassie blue detection kit was obtained from 
Nanjing Jiancheng Bioengineering Institute 
(Nanjing City, China). Other reagents were of 
analytical grade. 
 
Instruments and equipment   
 
Visible spectrophotometer was product of 
Shanghai Precision Scientific Instrument Co., 
Ltd, Model 722S; electronic balance: ZA1003 
(Sartorius (Shanghai) Trading Company Ltd); 
low-speed large-capacity desktop centrifuge was 
obtained from Shanghai Anting Scientific 
Instrument Factory (Shanghai, China); model 
TDL-5, trace desktop centrifuge model CL17R, 
was product of Thermo Company (Shanghai, 
China); high-speed refrigerated centrifuge was 
from Shanghai Anting Scientific Instrument 
Factory (Shanghai, China); model TGL-16G-A 
and vortex mixer were products of Shanghai 
Medical Instrument Factory (Shanghai, China). 
Water ultra-purification System (Model UPT-II-
20T) was supplied by Chengdu Chaochun 
Technology Co., Ltd (Sichuan Province, China); 
stainless steel electric heated-water bath, model 
GSY-ⅱ was from Beijing Medical Equipment 
factory (Beijing, China); while color pathological 
image analysis system PTPS-2011 was supplied 
by Chongqing Tianhai Medical Equipment Co., 




Healthy Kunming mice of both sexes (mean 
weight = 20 ± 2 g) were randomly assigned to six 
groups, with each group having 5 male and 5 
female mice. The groups were normal control 
group, CCl4 model group, biphenyldicarboxylate 
(BPDC, (150 mg/kg body weight) positive control 
group, and three groups given different doses 
(high, medium and low) of alcohol leaf extract of 
Yulangsan, i.e., YLSLH, YLSLM, YLSLL groups 
which received 30, 15 and 7.5 g YLSL/kg body 
weight, respectively. Mice in positive control 
group received intraperitoneally (i.p.) 0.02 mL 
ml/g; the CCl4 model group received the same 
dose of NS i.p. while mice in the treatment 
groups received their respective doses of YLSL 
i.p., in addition to NS. All treatments were given 
once daily for 7 days, and 1 h after the last 
administration, all the groups were injected with 
0.1 % CCl4 in peanut oil [10] at a dose of 0.1 
mL/10 g, except the normal control group which 
got peanut oil injection in place of 0.1 % CCl4 (0.1 
mL/10 g). The mice fasted for 16 h but had free 
access to drinking water, and the D-GalN model 
group was given (i.p.) D-GalN solution (800 
mg/kg) with the capacity of 0.2 mL/10 g [11], and 
fasted for 16h with access to drinking water [12]. 
 
Determination of serum biochemical 
indicators 
 
Blood was taken from the retro-orbital plexus, 
allowed to coagulate, and centrifuged at 3000 
rpm at 0 °C for 10 min. The serum was stored at 
-5 °C, and used for assay of serum AST and ALT 
with kits according to manufacturer’s instructions. 
 
Calculation of visceral indices of liver, spleen 
and thymus 
 
The mice were sacrificed by decapitation; the fat 
and mesentery were quickly cut off on an ice tray 
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in an ice-water bath of physiological saline. The 
liver, spleen and thymus were excised and rinsed 
with ice-cold physiological saline to remove 
accumulated blood. The organs were blotted and 
weighed; and visceral indices were calculated as 
follows: liver index = liver weight (g) divided by 
body weight (g), thymus index = thymus weight 
(mg) divided by body weight (g) and spleen index 
= spleen weight (mg) divided by body weight (g). 
 
Preparation of liver homogenates and 
examination 
 
The right lobe of the liver was selected and 
rinsed with cold saline to remove blood clots, 
then weighted after blotting. Ten percent (10 %) 
liver homogenate was prepared in 0.9 % sodium 
chloride solution. The homogenate was 
centrifuged at 3500 rpm at 4 oC for 15 min, and 
the supernatant was refrigerated at -5 °C prior to 
use. 
 
Biochemical indices in liver homogenate were 
assayed with kits were MDA (with thiobarbituric 
acid); SOD (xanthine oxidase method); GSH and 
GSH-PX, while protein content was determined 
by the Coomassie brilliant blue method [13]. 
 
Histological examination of liver tissue 
 
Small sections of liver tissue were taken 0.5 cm 
from the edge of liver leaf edge, and fixed in 10 
% formalin fixative at 4 oC overnight. The tissue 
was sectioned (cut into about 2 mm thickness) 
and HE stained, then the morphological changes 





SPSS 18.0 software was applied for statistical 
analysis. The data are presented as mean ± 
standard deviation (SD). The means of multi-
groups were compared using analysis of 





Effect of YLSL on visceral index of mice  
 
For mice with CCl4-induced acute liver injury, 
both YLSLH and YLSLM significantly reduced 
thymus index (p < 0.01). YLSLH reduced spleen 
index (p < 0.01). However, the different doses of 
YLSL had no significant effect on liver index. 
 
For mice with D-GalN-induced acute liver injury, 
the three doses of YLSL had no significant effect 
on liver index and spleen index. However YLSLH 
significantly lowered thymus index (p < 0.05; 
Table 1). 
 
Effect of YLSL on serum biochemical 
parameters 
 
Experimental results demonstrated that for 
mice with CCl4-induced acute liver injury, YLS 
leaf alcohol extract at low dose significantly 
reduced the activity of serum AST (p < 0.01), 
while the middle dose significantly reduced the 
activity of serum ALT (p < 0.05).High dose of 
the extract resulted in significant reduction of 
MDA (p < 0.05), while each of the three doses 
significantly enhanced the activities of SOD 
and GSH-PX (p < 0.01). 
 
For mice with D-GalN-induced acute liver injury, 
low dose of YLS leaf alcohol extract reduced 
the activity of serum AST (p < 0.01); each dose 
significantly decreased serum ALT activity 
(low- and middle-dose: p <0.01, high dose: p < 
0.05). 
 
Middle- and high-doses resulted in significantly 
decreased content of MDA (p <0.01 or <0.05), 
while each of the three dose significantly 
increased GSH content (high- and middle- 
 
Table 1: Effect of YLSL on liver, spleen and thymus indices in CCl4 or D-GalN-induced acute liver injury in mice 
 





NC 0.0460±0.0037 4.0807±0.7729 3.7120±0.8534 
CCl4 model 0.0472±0.0033 3.8743±0.9183 4.4213±1.0544 
BPDC+CCl4 0.0506±0.0047 4.3336±0.5902 3.8805±1.2399 
YLSLL+CCl4 0.0479±0.0033 4.3535±0.9405 3.8722±1.8661 
YLSLM+CCl4 0.0496±0.0035 3.4046±0.6768 2.8778±0.5853** 
YLSLH +CCl4 0.0498±0.0037 3.2068±0.3859* 2.7682±0.7235** 
NC 0.0474±0.0097 4.1739±0.7232 3.7654±1.0897 
D-GalN model 0.0543±0.0049 4.1427±1.4056 3.7272±1.1655 
BPDC+D-GalN 0.0631±0.0061** 4.5190±0.9977 3.9386±0.8912 
YLSLL+D-GalN 0.0567±0.0113 4.5056±0.7446 3.3667±1.4537 
YLSLM+D-GalN 0.0563±0.0081 3.7721±1.2645 3.1694±0.8226 
YLSLH+D-GalN 0.0571±0.0073 3.0471±0.9327 1.9548±1.2996* 
Values expressed are as mean ± SD (n = 10); *p < 0.05, **p < 0.01 vs CCl4 control and D-GalN control group 
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dose: p < 0.01, low dose: p < 0.05). However, 
each dose significantly increased SOD activity 
(p < 0.01) (Table 2). 
 
Effect of YLSL on liver histopathology CCl4-
and D-GalN-induced acute liver injury 
 
Under the microscope, clear clobular contours, 
prominent nucleoli, abundant and uniform 
cytoplasm of hepatocytes, and visible liver 
sinusoidal cord could be seen in normal mice. 
After acute liver injury, hepatic lobules were 
unclear, the cytoplasm was bright and empty 
with sparse, lightly stained, irregular particles, 
and the liver cells became enlarged.  Besides 
ballooning degeneration, nuclear condensation 
and focal necrosis were evident. However, 
each dose of YLSL relieved the liver cell 
swelling, as well as focal and zonal necrosis. 




There are varieties of enzymes which reflect liver 
cell injury and the extent of damage. These 
include ALT, AST, GGT, GLD, and SOD. ALT is 
the most sensitive indicator of liver cell injury 
[14]. In general, increased activity of serum ALT 
is positively correlated with degree of 
hepatocellular disease. Increased serum AST 
and ALT activities are of significance in the 
diagnosis of hepatitis, although ALT is a more 
reliable index than ALT. The activities of ALT and 
ASTin the CCl4 and D-GalN models were 
significantly elevated, with variation in ALT 
greater than that in AST, suggesting that liver 
tissue damage was successfully induced in these 
models.  
 
MDA is the end product of lipid peroxidation, 
which indirectly reflects the severity of free 
radical attack on cells [15]. SOD is an important 
antioxidant enzyme system which indirectly 
reflects ability to scavenge oxygen free radicals 
[16,17]. Therefore, MDA levels are often 
correlated with SOD. In this study, SOD activities 
in the CCl4 and D-GalN models were significantly 
lower than SOD activities in the treatment groups 
(p < 0.01). This indicates that alcohol leaf extract 
of Yulangsan has hepatoprotective effects, most 
probably through inhibition of lipid peroxidation. 
GSH, a tripeptide composed of glutamic acid, 
cysteine and glycine, is an important non-protein 
thiol compound which belongs to low-molecular 
scavengers. GSH can eliminate O2-, H2O2 and 
LOOH, and is necessary for the decomposition of 
hydrogen peroxide. Besides, GSH can stabilize 
thiol-containing enzymes and prevent 
hemoglobin and other cofactors from oxidative 
damage. Deficiency of GSH or its depletion will 
lead to toxic effects or aggravated toxic effects 
by many chemicals or environmental factors. 
Thus, GSH is an index of antioxidant capacity. 
 
The determination of activities of GSH and GSH-
Px are useful for understanding the mechanism 
of drug action. In the treatment groups exposed 
to CCl4, GSH-Px activity was significantly 
increased (p < 0.01) and GSH levels decreased 
(middle dose group and positive control group). 
In the treatment groups with D-GalN, GSH 
content was significantly increased (p < 0.01 or p 
< 0.05), while GSH-Px activity decreased (p < 
0.01). 
 
Thus, an inverse relationship was observed 
between GSH and GSH-Px, i.e., when GSH 
reduced, GSH-Px increased, and vice versa. 
This suggests that the alcohol extract of 
Yulangsan on the one hand promoted the 
synthesis of GSH, while on the other hand, it 
accelerates the conversion of GSH to GSSG. 
 
Table 2: Effect of YLSL on serum and hepatic parameters in CCl4- and D-GalN-induced acute liver injured mice 
 





NC 72.72±23.69** 24.35±9.05** 2.46±0.43** 0.73±0.19* 160.31±20.25** 133.28±47.15 
CCl4model 107.13±21.70 97.71±29.50 4.04±1.10 0.94±0.36 123.33±28.33 172.62±49.86 
BPDC+CCl4 77.19±17.18** 22.25±10.88** 3.08±0.65* 0.65±0.13* 187.74±42.33** 362.60±42.81** 
YLSLL+CCl4 80.50±9.57** 66.58±27.98* 4.42±0.98 0.82±0.11 209.55±25.10** 412.52±54.94** 
YLSLM+CCl4 101.56±31.58 66.41±29.55* 3.55±0.66 0.65±0.11* 175.66±32.95** 319.80±56.90** 
YLSLH+CCl4 101.61±31.44 77.87±29.62 2.98±0.81* 1.02±0.18 165.36±35.34** 341.00±65.03** 
NC 50.47±41.69** 12.34±5.97** 6.70±3.31** 1.77±0.98 169.79±64.97 437.41±125.62 
D-GalN model 228.61±70.60 260.58±64.53 12.66±5.51 1.18±0.55 142.57±22.40 479.29±126.48 
BPDC+D-GalN 74.88±40.85** 77.36±72.93** 7.08±2.69** 4.72±5.22* 195.64±43.92** 323.74±49.54** 
YLSLL+D-GalN 118.83±93.71** 103.74±86.34** 10.89±5.58 4.01±4.05* 210.74±35.55** 365.62±65.52* 
YLSLM+D-GalN 163.70±155.36 135.22±97.96** 8.08±3.53* 2.38±0.93** 190.60±27.55** 289.77±76.09** 
YLSLH+D-GalN 210.67±109.91 138.19±138.57* 6.37±2.07** 4.19±3.06** 198.90±30.12** 333.56±68.27** 
Values expressed are as mean ± SD (n = 10); *p < 0.05, **p < 0.01 vs CCl4 control and D-GalN control groups 
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Figure 1: Photomicrograph of liver tissue (H&E ×100). a: oil alone-treated mice; b:CCl4 alone-
treated mice ; c: mice pretreated with YLSL (30g•kg-1•d-1×7d) before treatment with CCl4; d: mice 
pretreated with YLSL (15 g•kg-1•d-1×7d) before treatment with CCl4;e: pretreated with YLSL 
(7.5g•kg-1•d-1×7d) before treatment with CCl4; f: mice pretreated with BPDC (150mg•kg-1•d-
1×7d) before treatment with CCl4; g: NC alone-treated mice; h: D-GalN alone-treated mice; i: mice 
pretreated with YLSL (30g•kg-1•d-1×7d) before treatment with D-GalN; j: mice pretreated with 
YLSL (15g•kg-1•d-1×7d) before treatment with D-GalN; k: mice pretreated with YLSL (7.5g•kg-
1•d-1×7d) before treatment with D-GalN; l: mice pretreated with BPDC (150mg•kg-1•d-1×7d) 
before treatment with D-GalN 
 
Histological examination is a visual indicator of 
organ or tissue damage. In this study, CCl4-
induced liver damage was reflected in cellular 
necrosis, hemorrhage in the central vein and 
fatty degeneration. In the D-GalN model group, 
features seen in histology included diffuse 
multiple patchy necrosis, cells with a large 
number of toxic granule with positive PAS 
staining and more eosinophilic corpuscles. 
These features are similar to the damage 
caused by viral hepatitis. The different doses of 
Yulangsan leaf alcohol extract exhibited varying 
degrees of relief on the CCl4 and D-GalN-induced 
liver cell swelling, necrosis, fatty degeneration, 
inflammatory cell infiltration and other 
pathological changes. This shows that the extract 
has a protective effect against acute liver injury, 
through a mechanism involving neutralizing 





YLSL lowers the elevated activities of ALT, AST 
in acute liver injury mice-induced by CCl4 and D-
GalN, ameliorates liver pathological condition 
and have protective effects against CC14-
induced acute liver injury. The protective effects 
of wedelolactone against CCl4 and D-GalN-
induced acute liver injury are related to its ability 
to attenuate oxygen free radicals and inhibit lipid 
peroxidation. The results of this study provide a 
further understanding of the pharmacological 
effects of YLSL as well as the need for further 
studies of the plant. 
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